Your search history is turned on.
Date: May 7, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
NervGen Files Management Information Circular and Announces Board of Directors Transition Bill Radvak to transition to Board Advisor following decision to not stand for re-election to NervGen's Board of Directors Annual General Meeting of Shareholders to be held on June 4, 2024 Vancouver, British Columbia--(Newsfile Corp. - May 7, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("Ne...
Date: May 6, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
Security Class Holder Account Number Voting Instruction Form ("VIF") - Annual General Meeting to be held on June 4, 2024 NON-REGISTERED (BENEFICIAL) SECURITYHOLDERS 1. We are sending to you the enclosed proxy-related materials that relate to a meeting of the holders of the series or class of securities that are held on your behalf by the intermediary ide...
Security Class Holder Account Number Form of Proxy - Annual General Meeting to be held on June 4, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any ad...
Under securities regulations, a reporting issuer must send annually a form to holders to request the Interim Financial Statements and MD&A and/or the Annual Financial Statements and MD&A. If you would like to receive the report(s) by mail, please make your selection and return to the address as noted or register online at www.computershare.com/mailinglist. A...
2 NERVGEN PHARMA CORP. 112-970 Burrard Street, Unit 1290, Vancouver, BC V6Z 2R4 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT the annual meeting (the Meeting) of shareholders of NervGen Pharma Corp. (the Corporation) will be held at 1133 Melville Street, Suite 3500, The Stack, Vancouver, British Columbia V6E 4E5, on Tuesday, June 4, 2024,...
NOTICE OF MEETING AND MANAGEMENT PROXY CIRCULAR FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD AT 1:00 P.M. (PT) ON TUESDAY, JUNE 4, 2024 AT 1133 MELVILLE STREET, SUITE 3500, THE STACK, VANCOUVER, BRITISH COLUMBIA V6E 4E5 2 NERVGEN PHARMA CO...
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
NervGen Engages Russo Partners LLC to Provide Public Relations Services Vancouver, British Columbia--(Newsfile Corp. - April 25, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that it has engaged Russo Partners LLC ("Russo Partn...
Date: April 17, 2024 Jurisdictions: Alberta, British Columbia, Nova Scotia, Ontario
NervGen Pharma Reports 2023 Year-End Financial Results and Operational Updates Anticipated completion of enrollment of the chronic cohort in the Phase 1b/2a clinical trial in Q2 2024 CA$23 million bought deal financing completed in March 2024 provides expected cash runway through Q3 2025 Fast Track designation granted by U.S. Food and Drug Administration (FDA) for NVG-291 in spinal cord injury ...
Date: April 17, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, ADAMS, William, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...